ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Clinical trials for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug tested in fight against sudden, severe lung failure
Disease control OngoingThis study is testing a new antibody drug called ALT-100 in hospitalized adults with moderate to severe Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of lung failure. The main goals are to see if the drug is safe and if it can help patients breathe without a…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Can you tell the doctor from the robot? AI steps into the ICU
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if an artificial intelligence (AI) system can give safe and appropriate treatment advice for serious ICU conditions like sepsis and ARDS. It involves 350 critical care doctors and nurses reviewing simulated patient cases and judging the treatment plans. The…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC